Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has scheduled its first quarter 2025 financial results conference call and webcast for Tuesday, April 29, 2025 at 8:30 a.m. Eastern Time. The company will discuss Q1 2025 financial performance and recent portfolio developments.
The event will be accessible through a live webcast in the Investors & Media section of www.kiniksa.com. Interested participants can register for telephone access, after which they will receive confirmation details including dial-in information and unique access credentials. A replay will be available on the company website within 48 hours after the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha programmato la conference call e la diretta web dei risultati finanziari del primo trimestre 2025 per martedì 29 aprile 2025 alle 8:30 ora orientale. La società discuterà delle performance finanziarie del primo trimestre 2025 e degli ultimi sviluppi del portafoglio.
L'evento sarà accessibile tramite una diretta web nella sezione Investitori & Media di www.kiniksa.com. I partecipanti interessati possono registrarsi per accedere telefonicamente, ricevendo successivamente i dettagli di conferma, inclusi i numeri di accesso e le credenziali uniche. Una registrazione sarà disponibile sul sito aziendale entro 48 ore dall'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha programado su conferencia telefónica y webcast de resultados financieros del primer trimestre de 2025 para el martes 29 de abril de 2025 a las 8:30 a.m., hora del Este. La compañía discutirá el desempeño financiero del primer trimestre de 2025 y los desarrollos recientes de su portafolio.
El evento será accesible mediante una transmisión en vivo en la sección de Inversores y Medios de www.kiniksa.com. Los interesados pueden registrarse para acceder por teléfono, tras lo cual recibirán los detalles de confirmación, incluyendo la información para marcar y credenciales únicas de acceso. Una grabación estará disponible en el sitio web de la compañía dentro de las 48 horas posteriores al evento.
Kiniksa Pharmaceuticals (나스닥: KNSA)는 2025년 1분기 재무 실적 컨퍼런스 콜 및 웹캐스트를 2025년 4월 29일 화요일 오전 8시 30분(동부 시간)에 예정했습니다. 회사는 2025년 1분기 재무 성과와 최근 포트폴리오 개발 사항을 논의할 예정입니다.
해당 행사는 www.kiniksa.com의 투자자 및 미디어 섹션에서 라이브 웹캐스트로 시청할 수 있습니다. 관심 있는 참가자는 전화 접속 등록을 할 수 있으며, 등록 후 다이얼인 정보와 고유 접속 자격 증명을 포함한 확인 정보를 받게 됩니다. 행사 종료 후 48시간 이내에 회사 웹사이트에서 재방송을 시청할 수 있습니다.
Kiniksa Pharmaceuticals (Nasdaq : KNSA) a programmé sa conférence téléphonique et son webcast des résultats financiers du premier trimestre 2025 pour le mardi 29 avril 2025 à 8h30, heure de l'Est. La société discutera des performances financières du premier trimestre 2025 ainsi que des récents développements de son portefeuille.
L'événement sera accessible via un webcast en direct dans la section Investisseurs & Médias du site www.kiniksa.com. Les participants intéressés peuvent s'inscrire pour un accès téléphonique, après quoi ils recevront les détails de confirmation, y compris les informations de connexion et des identifiants uniques. Un replay sera disponible sur le site de la société dans les 48 heures suivant l'événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine Telefonkonferenz und Webcast zu den Finanzergebnissen des ersten Quartals 2025 für Dienstag, den 29. April 2025, um 8:30 Uhr Eastern Time, angesetzt. Das Unternehmen wird die Finanzergebnisse des ersten Quartals 2025 sowie aktuelle Entwicklungen im Portfolio besprechen.
Die Veranstaltung ist über einen Live-Webcast im Bereich Investoren & Medien auf www.kiniksa.com zugänglich. Interessierte Teilnehmer können sich für den Telefonzugang registrieren, woraufhin sie Bestätigungsdetails einschließlich Einwahlinformationen und eindeutigen Zugangsdaten erhalten. Eine Aufzeichnung wird innerhalb von 48 Stunden nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 29, 2025 at 8:30 a.m. Eastern Time to report its first quarter 2025 financial results and recent portfolio execution.
A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts!®
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
FAQ
When will Kiniksa Pharmaceuticals (KNSA) release Q1 2025 earnings?
How can investors access KNSA's Q1 2025 earnings call?
Will there be a replay available for Kiniksa's Q1 2025 earnings call?
What topics will be covered in KNSA's Q1 2025 earnings call?
